AtaiBeckley

Eli Lilly paid $2.8B for psychedelics company AtaiBeckley

Shaan cites Eli Lilly's roughly $2.8 billion purchase of AtaiBeckley, which he calls probably the biggest psychedelic acquisition ever. He uses it to show how fast a fringe intervention can become accepted, with the same path possible for peptides and oxytocin.

“It's probably the biggest psychedelic acquisition ever. This company called— I don't know how you say it— Atai Beckley. They just got bought for $2.8 billion. And psychedelics are the same sort of thing, right? Like, growing up, psychedelics were seen as a certain way, right? It's like tripping balls and it's a way to have a good time.”